Serum globotriaosylceramide assay as a screening test for fabry disease in patients with ESRD on maintenance dialysis in Korea (Q34385057)

1 August 2017

Serum globotriaosylceramide assay as a screening test for fabry disease in patients with ESRD on maintenance dialysis in Korea (English)

1 reference

1 August 2017

0 references

1 reference

Jeong-Yup Kim

1

1 reference

1 August 2017

Young-Youl Hyun

2

1 reference

1 August 2017

Ji-Eun Lee

3

1 reference

1 August 2017

Hye-Ran Yoon

4

1 reference

1 August 2017

Gu-Hwan Kim

5

1 reference

1 August 2017

Han-Wook Yoo

6

1 reference

1 August 2017

Seong-Tae Cho

7

1 reference

1 August 2017

No-Won Chun

8

1 reference

1 August 2017

Byoung-Chunn Jeoung

9

1 reference

1 August 2017

Hwa-Jung Kim

10

1 reference

1 August 2017

Keong-Wook Kim

11

1 reference

1 August 2017

Seong-Nam Kim

12

1 reference

1 August 2017

Yung-A Kim

13

1 reference

1 August 2017

Hyun-Ah Lee

14

1 reference

1 August 2017

Jong-Young Lee

15

1 reference

1 August 2017

Yung-Chun Lee

16

1 reference

1 August 2017

Hun-Kwan Lim

17

1 reference

1 August 2017

Keong-Sik Oh

18

1 reference

1 August 2017

Seong-Hwan Son

19

1 reference

1 August 2017

Beong-Hee Yu

20

1 reference

1 August 2017

Kyeong-So Wee

21

1 reference

1 August 2017

Eun-Jong Lee

22

1 reference

1 August 2017

Young-Ki Lee

23

1 reference

1 August 2017

Jung-Woo Noh

24

1 reference

1 August 2017

Seung-Jung Kim

25

1 reference

1 August 2017

Kyu-Bok Choi

26

1 reference

1 August 2017

Suk-Hee Yu

27

1 reference

1 August 2017

Heui-Jung Pyo

28

1 reference

1 August 2017

Young-Joo Kwon

29

1 reference

1 August 2017

27 November 2010

1 reference

The Korean journal of internal medicine

1 August 2017

1 reference

1 August 2017

25

1 reference

1 August 2017

4

1 reference

1 August 2017

415-421

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

1 August 2017

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Short-term efficacy of enzyme replacement therapy in Korean patients with Fabry disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Is globotriaosylceramide a useful biomarker in Fabry disease?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

The pathogenesis of glycosphingolipid storage disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Renoprotection by enzyme replacement therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Fabry disease in childhood

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Biochemical and molecular genetic basis of Fabry disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Falsely elevated urinary Gb3 (globotriaosylceramide, CTH, GL3).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Patients with Fabry disease on dialysis in the United States

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997971

Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype

27 October 2018

1 reference

12 December 2020

Molecular analysis in Fabry disease in Spain: fifteen novel GLA mutations and identification of a homozygous female

1 reference

12 December 2020

Results of a nationwide screening for Anderson-Fabry disease among dialysis patients

1 reference

12 December 2020

Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease

1 reference

12 December 2020

An atypical variant of Fabry's disease in men with left ventricular hypertrophy

1 reference

12 December 2020

Isolated glomerular proteinuria as the only clinical manifestation of Fabry's disease in an adult male

1 reference

12 December 2020

Fabry disease in patients with end-stage renal failure: the potential benefits of screening

1 reference

12 December 2020

Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry

1 reference

12 December 2020

10.3904/KJIM.2010.25.4.415

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference